Efficacy of Group Reminiscence Therapy on Cognition,Depression,Neuropsychiatric Symptoms,and Activities of Daily Living for Patients With Alzheimer Disease
Restricted accessResearch articleFirst published online September, 2020
Efficacy of Group Reminiscence Therapy on Cognition,Depression,Neuropsychiatric Symptoms,and Activities of Daily Living for Patients With Alzheimer Disease
The current study aimed to investigate the effects of group reminiscence therapy on cognitive function, depression, neuropsychiatric symptoms, and activities of daily living in patients with mild-to-moderate Alzheimer disease (AD). A single-blind randomized parallel-design controlled trial was conducted between May 1, 2017, and April 30, 2018. Ninety patients with mild-to-moderate AD recruited from Beijing Geriatric Hospital were randomly allocated into intervention (n = 45) and control groups (n = 45). In the intervention group, group-based reminiscence therapy was performed in two 30- to 45-minute sessions weekly for 12 weeks. Control participants received only conventional drug treatments and routine daily care. Alzheimer disease–related symptoms were evaluated using the Alzheimer’s Disease Assessment Scale-Cognitive section, the Cornell Scale for Depression in Dementia (CSDD), the Neuropsychiatric Inventory, and the Barthel Index. Four time points were set for data collection: baseline (before treatment), 4 weeks (during treatment), 12 weeks (end of treatment), and 24 weeks (12 weeks posttreatment). χ2 Tests, independent t tests, repeated-measures analysis of variance, and Bonferroni tests were used for data analysis. Significant improvements in depressive and neuropsychiatric symptoms were found in the intervention group compared to the control group (P < .05). Mean CSDD scores in the intervention group were improved at all 3 time points compared to baseline and showed the greatest effect at 12 weeks (t = 2.076, P = .041) and 24 weeks follow-up (t = 3.834, P = .000) compared to controls. Group reminiscence therapy was effective for improving depressive symptoms and was beneficial for treating neuropsychiatric symptoms in patients with AD.
ChiangKJChuHChangHJ, et al.The effects of reminiscence therapy on psychological Well-being, depression, and loneliness among the institutionalized aged. Int J Geriatr Psychiatry. 2010;25(4):380–388.
3.
KishitaNBackhouseTMioshiE. Nonpharmacological interventions to improve depression, anxiety, and quality of life (QoL) in people with dementia: an overview of systematic reviews [published online June 16, 2019]. J Geriatr Psychiatry Neurol. 2019.
4.
LazarAThompsonHDemirisG. A systematic review of the use of technology for reminiscence therapy. Health Educ Behav. 2014;41:51S–61S.
5.
Ingersoll-DaytonBKropfNCampbellRParkerM. A systematic review of dyadic approaches to reminiscence and life review among older adults. Aging Ment Health. 2018;31(9):
1–12.
6.
O’ PhilbinLWoodsBFarrellEMSpectorAEOrrellM. Reminiscence therapy for dementia: an abridged Cochrane systematic review of the evidence from randomized controlled trials. Expert Rev Neurother. 2018;18(9):715–727.
7.
ImtiazDKhanASeelyeA. A mobile multimedia reminiscence therapy application to reduce behavioral and psychological symptoms in persons with alzheimer’s. J Healthc Eng. 2018;2018:1536316.
8.
AstellAJSmithSKPotterSPreston-JonesE. Computer interactive reminiscence and conversation aid groups-delivering Cognitive stimulation with technology. Alzheimers Dement (N Y). 2018;4:481–487.
9.
GonzalezJMayordomoTTorresMSalesAMeléndezJC. Reminiscence and dementia: a therapeutic intervention. Int Psychogeriatr. 2015, 27(10):1731–1737.
10.
Duru AşiretGKapucuS. The effect of reminiscence therapy on cognition, depression, and activities of daily living for patients with alzheimer disease. J Geriatr Psychiatry Neurol. 2016;29(1):
31–37.
11.
Van BogaertPVan GrinsvenRTolsonD, et al.Effects of SolCos model-based individual reminiscence on older adults with mild to moderate dementia due to alzheimer disease: a pilot study. J Am Med Dir Assoc. 2013;14(528):
e9–e13.
12.
CharlesworthGBurnellKCrellinN, et al.Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. J Neurol Neurosurg Psychiatry. 2016;87(11):1218–1228.
13.
LökNBademliKSelçuk-TosunA. The effect of reminiscence therapy on cognitive functions, depression, and quality of life in alzheimer patients: randomized controlled trial. Int J Geriatr Psychiatry. 2019;34(1):47–53.
14.
ChuehKHChangTY. Effectiveness of group reminiscence therapy for depressive symptoms in male veterans: 6 month follow up. Int J Geriatr Psychiatry. 2014;29(4):377–383.
15.
MoralJCMCharcoRLRodríguezTM, et al.Effects of a reminiscence program among institutionalized elderly adults. Psicothema. 2013;25(3):319–323.
16.
ChaoSYLiuHYWuCY, et al.The effects of group reminiscence therapy on depression, self esteem, and life satisfaction on elderly nursing home residents. J Nurs Res. 2006;14(1):36–45.
17.
ParkKLeeSYangJSongTHongGS. A systematic review and meta-analysis on the effect of reminiscence therapy for people with dementia. Int Psychogeriatr. 2019;4:1–17.
18.
WuLFKooM. Randomized controlled trial of a six-week spiritual reminiscence intervention on hope, life satisfaction, and spiritual well-being in elderly with mild and moderate dementia. Int J Geriatr Psychiatry. 2016;31(2):120–127.
19.
AkanumaKMeguroKMeguroM, et al.Improved social interaction and increased anterior cingulate metabolism after group reminiscence with reality orientation approach for vascular dementia. Psychiatry Res. 2011;192(3):183–187.
20.
PinquartMForstmeierS. Effects of reminiscence interventions on psychosocial outcomes: a meta-analysis. Aging Ment Health. 2012;16(5):541–558.
21.
McKhannGMKnopmanDSChertkowH, et al.The diagnosis of dementia due to alzheimer’s disease: recommendations from the national institute on aging-alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):263–269.
22.
WoodsBO’PhilbinLFarrellEM, et al.Reminiscence therapy for dementia. Cochrane Database Syst Rev. 2018;3:CD001120.
23.
JiaJWeiCChenS, et al.The cost of Alzheimer’s disease in china and re-estimation of costs worldwide. Alzheimers Dement. 2018;14(4):483–491.
24.
YenHYLinL. A systematic review of reminiscence therapy for older adults in Taiwan. J Nurs Res. 2018;26(2):138–150.
25.
AthertonNBridleCBrownD, et al.Dementia and Physical Activity (DAPA) - an exercise intervention to improve cognition in people with mild to moderate dementia: study protocol for a randomized controlled trial. Trials. 2016;17:165.
26.
MavrosYGatesNWilsonGC, et al.Mediation of cognitive function improvements by strength gains after resistance training in older adults with mild cognitive impairment: outcomes of the study of mental and resistance training. J Am Geriatr Soc. 2017;65(3):
550–559.
27.
RosenWGMohsRCDavisKL. A new rating scale for Alzheimer’s disease. Am J Psychiatry. 1984;141(11):1354–1364.
28.
WangHLShuLSiTM. Validity and reliability of Chinese version of Alzheimer’s disease assessment scale. Zhongguo linchuang xinlixue zazhi. 2000;8:89–93.
29.
YuXWangHLLiSR. Discriminatory potential of the Chinese version of ADAS-Cog for mild versus moderate Alzheimer disease. Zhongguo Xinli Weisheng Zazhi. 2005;19:31–33.
30.
AlexopoulosGSAbramsRCYoungRC, et al.Cornell scale for depression in dementia. Biol Psychiatry. 1988;23(3):271–284.
31.
RenRJWangGZhangS, et al.Validation of the Chinese version of the Cornell scale for depression in dementia and its applications for clinical research. Zhongguo Linchuang Shenjing Kexue. 2008;16:170–174.
32.
CummingsJLMegaMGrayKThompsonSRCarusiDAGornbeinJ. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308–2314.
33.
MaWXWangHLJeffreyL, et al.Reliability and validity of Chinese version of neuropsychiatric inventory-questionnaire inpatients with Alzheimer’s disease. Zhongguo Xinli Weisheng Zazhi. 2010;24(5):
338–342.
34.
SulterGSteenCDe KeyserJ. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke. 1999;30(8):1538–1541.
35.
HouDZZhangYWuJLBiRXFangXQHuM. Study on reliability and validity of Chinese version of Barthel index. Linchuang Huicui. 2012;27:219–221.
36.
IhlRFerrisSRobertPWinbladBGauthierSTennigkeitF. Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer’s disease. Int J Geriatr Psychiatry. 2012;27(1):15–21.
37.
İnel ManavASimsekN. The effect of reminiscence therapy with internet-based videos on cognitive status and apathy of older people with mild dementia. J Geriatr Psychiatry Neurol. 2019;32(2): 104–113.
38.
NakatsukaMNakamuraKHamanosonoR, et al.A cluster randomized controlled trial of nonpharmacological interventions for old-old subjects with a clinical dementia rating of 0.5: the Kurihara project. Dement Geriatr Cogn Dis Extra. 2015;5(2):221–232.
39.
HuangHCChenYTChenPY, et al.Reminiscence therapy improves cognitive functions and reduces depressive symptoms in elderly people with dementia: a meta-analysis of randomized controlled trials. J Am Med Dir Assoc. 2015;16(12):1087–1094.
40.
SiverováJBužgováR. The effect of reminiscence therapy on quality of life, attitudes to ageing, and depressive symptoms in institutionalized elderly adults with cognitive impairment: a quasi-experimental study. Int J Ment Health Nurs. 2018;27(5):1430–1439.
41.
PishvaeiMAtaie MoghanlooRAtaie MoghanlooV. The efficacy of treatment reminders of life with emphasis on integrative reminiscence on self-esteem and anxiety in widowed old men. Iran J Psychiatry. 2015;10(1):19–24.
42.
Serrani AzcurraDJ. A reminiscence program intervention to improve the quality of life of long-term care residents with Alzheimer’s disease: a randomized controlled trial. Braz J Psychiatry. 2012;34(4):422–433.
